Biotech Startups
9,603 companies tagged Biotech, with their investors and founders.
Mindstate Design Labs is a clinical-stage drug development company that uses AI to map the biological basis of emotion and cognition, synthesizing psychedelic phenomenology and biochemical data to design pharmaceutical compounds that induce specific therapeutic emotional and cognitive states for mental health treatment.
4 investors
Mineralys Therapeutics is a clinical-stage pharmaceutical company developing lorundrostat, a treatment targeting dysregulated aldosterone. It focuses on cardio-renal-metabolic diseases, including hypertension and chronic kidney disease.
4 investors
Mirum Pharmaceuticals is a biopharmaceutical company that develops and delivers therapies for people living with rare diseases. It operates in the U.S. and Europe, engaging with healthcare professionals, patients, and payers within applicable regulatory frameworks.
4 investors
Mission Therapeutics develops therapeutics targeting deubiquitylating enzymes (DUBs), such as USP30, which regulate ubiquitylation and processes including mitophagy and protein homeostasis. It operates in the biotech and drug discovery field focused on DUB biology.
4 investors
MitoRx is a preclinical-stage biotech developing MTRX31, a first-in-class small molecule that restores mitochondrial metabolism to eliminate ectopic fat in patients with metabolically unhealthy, high-risk obesity. Rather than suppressing appetite, its approach aims to deliver durable weight loss and reduce risks of type 2 diabetes, MASH, and cardiovascular disease.
4 investors
Mother Science creates biotech-based skincare products featuring Malassezin, a naturally-occurring molecule, for consumers seeking scientifically-validated beauty solutions. The company focuses on efficacious ingredients with rigorous safety standards and excludes common potentially harmful compounds from its formulations.
4 investors
Multiomic Health applies systems biology and data science to omics datasets for drug discovery and development in cardiometabolic and related diseases, working through R&D partnerships with biopharma organizations. The company combines computational biology and translational science to advance therapeutic candidates.
4 investors
Muna Therapeutics is a biotechnology company that discovers and develops therapies aimed at slowing or stopping neurodegenerative diseases, including Alzheimer's and Parkinson's. It operates in neurology-focused drug discovery and development.
4 investors
MycoTechnology develops food and beverage ingredients using mushroom mycelial fermentation, creating flavor modulation and sugar-reduction solutions for formulators, chefs, and R&D professionals. Founded in 2013, the company focuses on cleaner-label, better-tasting ingredients for the food industry.
4 investors
MyKor is a female-founded company with a team experienced in construction, manufacturing, materials science, engineering and biotechnology. It operates across three sites in the UK and Portugal.
4 investors
Developed next-generation depression pharmaceuticals; acquired in 2015 for $560M upfront plus milestones.
4 investors
nChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications. The company works with academic founders and institutional investors focused on advancing gene therapy treatments.
4 investors
Nebula Genomics offers whole genome sequencing, providing consumers with health, trait, ancestry, and oral microbiome reports based on 100% of their DNA. Its DNA Complete product delivers 350+ personalized genetic reports across categories such as cardiovascular health, brain health, and wellness.
4 investors
Clinical-stage biotech developing neoantigen-targeted T cell receptor (TCR) therapies for cancer; acquired by AstraZeneca.
4 investors
Neopenda develops health-technology devices for neonatal care in emerging markets, specifically serving healthcare facilities in underserved populations. The company, structured as a public benefit corporation, focuses on innovative products to improve health outcomes in resource-limited settings.
4 investors
NeuraLight develops AI-powered digital biomarkers for neurological diseases including Alzheimer's, Parkinson's, and multiple sclerosis. The company uses signal processing and computer vision to enable clinical assessment and disease monitoring for healthcare providers and medical institutions.
4 investors
NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications. The company translates bioelectronic devices from preclinical research toward first-in-human studies and commercialization.
4 investors
Neuron23 is a biotech company using data science, human genetics, and functional genomics to develop precision medicines and companion diagnostics for neurodegenerative diseases, starting with an LRRK2 program for Parkinson's disease. It aims to match patient subsets defined by genetic drivers with targeted therapies for conditions such as Parkinson's and Alzheimer's.
4 investors
Neurona is a clinical-stage biotherapeutics company developing allogeneic, off-the-shelf regenerative neural cell therapies that integrate into neural circuits to treat chronic neurological disorders. Its pipeline includes neuronal, glial, and gene-edited cell therapy candidates led by NRTX-1001, an inhibitory neuron therapy for epilepsy.</parameter> <parameter name="founders">[]
4 investors
NewAmsterdam Pharma develops innovative therapies for cardiovascular disease and lipid-related conditions. The company aims to provide lipid-lowering treatments that help patients with cardiovascular risk manage their health.
4 investors
Newform Foods is a South African food technology company focused on food and biotech research, including cultivated meat and agri-innovation. It has launched the Newform Applied Biotech Centre at South Ormsby Estate in Lincolnshire, UK.
4 investors
NextBiomedical develops innovative polymer-based pharmaceutical and medical device technologies designed to overcome limitations of existing therapeutics. The company specializes in adhesive polymers, polysaccharides, and microparticle formulations for controlled drug delivery and enhanced biocompatibility.
4 investors
Nicoya develops instruments and platforms for protein interaction and dynamics analysis, including SPR (Revo, OpenSPR, Alto), millisecond HDX-MS (FastHDX), and circular dichroism systems for measuring binding, kinetics, structure, and stability. Its tools serve academic and biopharma scientists studying structural biology and biologics.
4 investors
Noema Pharma develops a late-stage portfolio of oral small molecule therapeutics for people with neurological and related disorders, targeting both orphan and larger indications with significant unmet medical needs. The company works with patients, caregivers, and healthcare professionals throughout discovery and clinical development.
4 investors